Free Seminar ◆ Proof of Drug Discovery Concepts and HCS in Biopharmaceutical Development
モレキュラーデバイスジャパン 東京本社
In recent years, with the emergence of new drugs that have advanced mechanisms of action, particularly biopharmaceuticals, we are facing more sophisticated challenges in the early stages of drug discovery, such as proof of drug concept and high-content screening. For example, in drug concept proof, there is a demand for the visualization of a seamless drug delivery system from tissue sections to the cellular level, as well as intracellular DDS evaluation of biopharmaceuticals at the organelle level. Additionally, in high-content screening, there is a growing focus on using organoids, which are closer to the in vivo environment than traditional flat cultures, requiring highly accurate high-content analysis. Therefore, in this webinar, Leica and Molecular Devices will present the latest imaging solutions to address these challenges. Date and Time: September 22, 2022 (Thursday) 10:00-10:45, 14:00-14:45 (same content for both sessions) Participation Fee: Free Format: Online only (Capacity: 200 participants) Application Deadline: September 21, 2022 (Wednesday)
-
Date and time Thursday, Sep 22, 2022
10:00 AM ～ 10:45 AM
It will be re-aired from 14:00 to 14:45. - Entry fee Free